Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Antiviral Res. 2016 Apr 6;131:19–25. doi: 10.1016/j.antiviral.2016.03.015

Figure 5. Examples of Series 1 medicinal chemistry analogs synthesized.

Figure 5

Approximately 28 analogs at either R1 or R2 were synthesized in an attempt to improve potency and physicochemical properties; activity against RSV in the CPE assay (EC50), solubility, and stability against human liver microsomes are indicated. Conservative changes to R2 were well tolerated, but less conservative modifications to the biaryl group resulted in a loss of activity.